Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

December 31, 2018

Conditions
Retained Products of Conception Post Abortion
Interventions
DRUG

Oral contraceptive

Daily oral contraceptive agent for 3 weeks (FLAME, containing 0.02 mg Ethinylestradiol and 0.075 mg Gestodene)

OTHER

Expectant management

No intervention and a follow up visit a wewk later

Sponsors
All Listed Sponsors
lead

Meir Medical Center

OTHER

NCT03230825 - Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products | Biotech Hunter | Biotech Hunter